João Leandro is a Translational Researcher at AccelBio, supporting drug discovery projects. João is a biochemist with experience in early drug discovery programs for several human rare disorders from genetic and biochemical validation of drug targets in cell and mouse models, assay development, HTS, hit validation and in vitro testing. He has also worked in enzyme replacement therapies using nanoparticles for delivery of human enzymes. For his work in Phenylketonuria, he was awarded the 2011 European Phenylketonuria Group Best Presentation in Basic Research. João Leandro holds a Bachelor in Applied Chemistry-Biotechnology from the FCT NOVA Lisbon, and a PhD in Pharmacy-Biochemistry from the Faculty of Pharmacy in Lisbon, in collaboration with the University of Bergen, Norway. He did two Post-doctoral studies: at the Faculty of Pharmacy in Lisbon, in collaboration with Ludwig-Maximilians-University, Germany, and at the Icahn School of Medicine at Mount Sinai Hospital, US.